Pacira BioSciences (PCRX) Convertible Debt (2013 - 2025)
Pacira BioSciences (PCRX) posted quarterly Convertible Debt of $280.3 million for Q2 2025, down 41.56% year-over-year from $479.5 million in Q2 2024, and little changed quarter-over-quarter from $279.8 million in Q1 2025.
Pacira BioSciences (PCRX) Convertible Debt (2013 - 2025) Analysis & Trends
Pacira BioSciences' Convertible Debt history runs 13 years deep, the most recent figure standing at $280.3 million for Q2 2025.
- In Q2 2025, Convertible Debt fell 41.56% year-over-year to $280.3 million; the TTM figure through Jun 2025 stood at $280.3 million (down 41.56% YoY), while the FY2024 annual figure was $279.3 million, down 29.92% from the prior year.
- Convertible Debt for Q2 2025 stood at $280.3 million, roughly flat from $279.8 million in the prior quarter.
- The five-year high for Convertible Debt was $479.5 million in Q2 2024, with the low at $278.9 million in Q3 2024.
- The 5-year median for Convertible Debt is $397.7 million (2023), against an average of $362.0 million.
- The sharpest annual moves came in 2022 and 2025: Convertible Debt grew 26.97% in 2022, then sank 41.56% in 2025.
- Pacira BioSciences' Convertible Debt stood at $339.3 million in 2021, then gained by 19.31% to $404.8 million in 2022, then declined by 1.53% to $398.6 million in 2023, then fell by 29.92% to $279.3 million in 2024, then grew by 0.33% to $280.3 million in 2025.
- Business Quant data shows PCRX's Convertible Debt at $280.3 million in Q2 2025, $279.8 million in Q1 2025, and $279.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Pacira BioSciences | 943.54 Mn | 692.51 Mn | 148.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 280.27 Mn |
| Mar 31, 2025 | 279.80 Mn |
| Dec 31, 2024 | 279.33 Mn |
| Sep 30, 2024 | 278.87 Mn |
| Jun 30, 2024 | 479.55 Mn |
| Mar 31, 2024 | 399.21 Mn |
| Dec 31, 2023 | 398.59 Mn |
| Sep 30, 2023 | 397.98 Mn |
| Jun 30, 2023 | 397.36 Mn |
| Mar 31, 2023 | 405.38 Mn |
| Dec 31, 2022 | 404.77 Mn |
| Sep 30, 2022 | 404.15 Mn |
| Jun 30, 2022 | 403.53 Mn |
| Mar 31, 2022 | 402.92 Mn |
| Dec 31, 2021 | 339.27 Mn |
| Sep 30, 2021 | 326.15 Mn |
| Jun 30, 2021 | 321.71 Mn |
| Mar 31, 2021 | 317.34 Mn |
| Dec 31, 2020 | 313.03 Mn |
| Sep 30, 2020 | 456.46 Mn |